Phase I Multicenter Study of Ruxolitinib and Duvelisib in Relapsed or Refractory T- or NK-Cell Lymphomas
ENROLLING
Trial ID:
NCT05010005 Protocol # :
22-248
Phase
I
Disease Sites
Non-Hodgkin's Lymphoma
Principal Investigator
Jacobsen, Eric
Site Research Nurses
Bresnahan, Caitlin
Kats, Vanessa
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-248
22-248